To investigate the requirement for PHD2 in AML initiation, we employed genetic approaches, beginning with a mouse model of AML driven by expression of Meis1 and Hoxa9, oncogenes that are frequently overexpressed in human AML25–27 and which drive leukemogenesis6. This evidence concerns the gene EGLN1 and acute myeloid leukemia.